CLSI NBS08

Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E

Clinical and Laboratory Standards Institute, 10/28/2019

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:28/10/2019

Pages:130

File Size:1 file , 8.1 MB

Note:This product is unavailable in Russia, Belarus

This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.

More CLSI standard pdf

CLSI I/LA20-A2

Evaluation Methods and Analytical Performance Characteristics of Immunological Assays for Human Immunoglobin E (IgE) Antibodies of Defined Allergen Specificities; Approved Guideline--Second Edition, ILA20A2E

$110.00 $221.24

CLSI QMS03-A3

Training and Competence Assessment; Approved Guideline--Third Edition; QMS03A3E

$149.00 $298.31

CLSI M39-A3

Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline--Third Edition, M39A3

$136.00 $272.19

CLSI GP16-A3 (R2018)

Urinalysis; Approved Guideline--Third Edition, GP16A3

$90.00 $180.00